BMO Capital analyst James Fotheringham maintains Visa (NYSE:V) with a Outperform and lowers the price target from $257 to $241.
After Regulatory Setback, Spectrum Pharma Secures Up To $65M In Debt Funding
Spectrum Pharmaceuticals Inc (NASDAQ:SPPI) entered into a five-year debt financing agreement with SLR Capital Partners for a term loan…